The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
Open accessAbstract
The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer–TLR-7/8a) and evaluated how different physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer–TLR-7/8a was the most important factor for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer–TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular approach in which protein antigens are site-specifically linked to temperature-responsive polymer–TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Self-citationCorrelates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
T-cell quality in memory and protection: implications for vaccine design
Seder, R. A., Darrah, P. A., & Roederer, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2274 · Cited by 1,548
Self-citationMultifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,378
Self-citationNanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8 + T Cell Immunity
Epstein, J. E., Tewari, K., Lyke, K. E., Sim, B. K. L., Billingsley, P. F., Laurens, M. B., Gunasekera, A., Chakravarty, S., James, E. R., Sedegah, M., et al. (2011) · Science · doi:10.1126/science.1211548 · Cited by 533
Self-citationSeymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Self-citationHepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Self-citationGerner, M. Y., Kastenmuller, W., Ifrim, I., Kabat, J., & Germain, R. N. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.011 · Cited by 425
Self-citationWille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., & Seder, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507484102 · Cited by 332
Self-citationNair-Gupta, P., Baccarini, A., Tung, N., Seyffer, F., Florey, O., Huang, Y., Banerjee, M., Overholtzer, M., Roche, P. A., Tampé, R., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.054 · Cited by 325
Moon, J. J., Suh, H., Li, A. V., Ockenhouse, C. F., Yadava, A., & Irvine, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112648109 · Cited by 312
de Titta, A., Ballester, M., Julier, Z., Nembrini, C., Jeanbart, L., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313152110 · Cited by 254
Jewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Scott, E. A., Stano, A., Gillard, M., Maio-Liu, A. C., Swartz, M. A., & Hubbell, J. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.060 · Cited by 221
Pockros, P. J., Guyader, D., Patton, H., Tong, M. J., Wright, T., McHutchison, J. G., & Meng, T.-C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.025 · Cited by 218
Rational design of small molecules as vaccine adjuvants
Wu, T. Y.-H., Singh, M., Miller, A. T., De Gregorio, E., Doro, F., D’Oro, U., Skibinski, D. A. G., Mbow, M. L., Bufali, S., Herman, A. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009980 · Cited by 176
Smirnov, D., Schmidt, J. J., Capecchi, J. T., & Wightman, P. D. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.061 · Cited by 174
SKEIKY, Y. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00302-x · Cited by 172
DEC-205 is a cell surface receptor for CpG oligonucleotides
Lahoud, M. H., Ahmet, F., Zhang, J.-G., Meuter, S., Policheni, A. N., Kitsoulis, S., Lee, C.-N., O’Keeffe, M., Sullivan, L. C., Brooks, A. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208796109 · Cited by 171
Ilyinskii, P. O., Roy, C. J., O’Neil, C. P., Browning, E. A., Pittet, L. A., Altreuter, D. H., Alexis, F., Tonti, E., Shi, J., Basto, P. A., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.027 · Cited by 171
Kastenmüller, K., Wille-Reece, U., Lindsay, R. W. B., Trager, L. R., Darrah, P. A., Flynn, B. J., Becker, M. R., Udey, M. C., Clausen, B. E., Igyarto, B. Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45416 · Cited by 167
Self-citationStructure−Activity Relationships in Human Toll-Like Receptor 7-Active Imidazoquinoline Analogues
Shukla, N. M., Malladi, S. S., Mutz, C. A., Balakrishna, R., & David, S. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100358c · Cited by 163
Designing and building the next generation of improved vaccine adjuvants
Brito, L. A., & O'Hagan, D. T. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.027 · Cited by 158
Liu, H., Kwong, B., & Irvine, D. J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101266 · Cited by 140
Kourtis, I. C., Hirosue, S., de Titta, A., Kontos, S., Stegmann, T., Hubbell, J. A., & Swartz, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061646 · Cited by 129
Self-Assembling Peptide-Polymer Hydrogels Designed From the Coiled Coil Region of Fibrin
Jing, P., Rudra, J. S., Herr, A. B., & Collier, J. H. (2008) · Biomacromolecules · doi:10.1021/bm800459v · Cited by 129
Phosphorothioate Oligodeoxynucleotides: Antisense or Anti-Protein?
Krieg, A. Μ., & Stein, C. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.241 · Cited by 127
Quinn, K. M., Costa, A. D. S., Yamamoto, A., Berry, D., Lindsay, R. W. B., Darrah, P. A., Wang, L., Cheng, C., Kong, W., Gall, J. G. D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202861 · Cited by 120
Self-citationGerster, J. F., Lindstrom, K. J., Miller, R. L., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049211v · Cited by 119
Tuberculosis vaccines – rethinking the current paradigm
Andersen, P. L., & Woodworth, J. S. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.04.006 · Cited by 117
Oh, J. Z., Kurche, J. S., Burchill, M. A., & Kedl, R. M. (2011) · Blood · doi:10.1182/blood-2011-04-348839 · Cited by 113
A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily
Savage, P. M., Horton, V. L., Moore, J. L., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.569 · Cited by 109
Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand
Wu, C. C. N., Hayashi, T., Takabayashi, K., Sabet, M., Smee, D. F., Guiney, D. D., Cottam, H. B., & Carson, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611624104 · Cited by 106
Nordly, P., Madsen, H. B., Nielsen, H. M., & Foged, C. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903018863 · Cited by 101
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
Arens, R., van Hall, T., van der Burg, S. H., OSSENDORP, F. A., & Melief, C. J. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.008 · Cited by 58
New bioerodable thermoresponsive polymers for possible radiotherapeutic applications
Hrubý, M., Kučka, J., Lebeda, O., Macková, H., Babič, M., Koňák, Č., Studenovský, M., Sikora, A., Kozempel, J., & Ulbrich, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.009 · Cited by 53
Beyond oncology — Application of HPMA copolymers in non-cancerous diseases☆
Liu, X.-M., Miller, S. C., & Wang, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.006 · Cited by 41
Vecchi, S., Bufali, S., Uno, T., Wu, T. Y.-H., Arcidiacono, L., Filippini, S., Rigat, F., & O’Hagan, D. T. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.01.002 · Cited by 34
Chou, H.-Y., Lin, X., Pan, W., Wu, P.-Y., Chang, C., Lin, T.-Y., Shen, H.-H., & Tao, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001875 · Cited by 33
The coiled coil motif in polymer drug delivery systems
Pechar, M., & Pola, R. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.01.003 · Cited by 32
Self-citationShi, H., Gong, C., Zhang, H., Wang, Y., Zhang, J., Luo, Z., Qian, Z., Wei, Y.-Q., & Li, Y. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.03.073 · Cited by 21
Cited by
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067
Nanoparticle Vaccines Against Infectious Diseases
Pati, R., Shevtsov, M., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 514
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Thermoresponsive polymer nanocarriers for biomedical applications
Bordat, A., Boissenot, T., Nicolas, J., & Tsapis, N. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.005 · Cited by 415
Metadata
- Authors
- Lynn, G. M., Laga, R., Darrah, P. A., Ishizuka, A. S., Balaci, A. J., Dulcey, A. E., Pechar, M., Pola, R., Gerner, M. Y., Yamamoto, A., Buechler, C. R., Quinn, K. M., Smelkinson, M. G., Vanek, O., Cawood, R., Hills, T., Vasalatiy, O., Kastenmüller, K., Francica, J. R., Stutts, L., Tom, J. K., Ryu, K. A., Esser-Kahn, A. P., Etrych, T., Fisher, K. D., Seymour, L. W., & Seder, R. A.
- Venue
- Nature Biotechnology
- Published
- 2015-10-26
- Volume
- 33
- Issue
- 11
- Pages
- 1201-1210
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2144733364
- Cited by
- 440
- References
- 51
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.